Mirella Salvatore is an Assistant Professor of Medicine at Weill Cornell Medicine. She obtained her M.D. cum laude from the Catholic University in Rome, Italy, and completed her internal medicine residency and fellowship in infectious diseases at the Icahn School of Medicine at Mount Sinai in New York City. At Mount Sinai she also completed a postdoctoral fellowship training in influenza virus. As a physician-scientist, Dr. Salvatore has focused her research on host responses and therapeutics for influenza, with a focus on the immune-compromised host, and vaccines development. More recently she has been working on the identification of host and viral predictors of progression to severe COVID-19, and SARS-CoV2 evolution in the immunocompromised host. She is part of the Editorial Board and Associate Editor of Frontiers in Medicine and Frontiers in Public Health, section of Infectious Diseases and Editorial Board Member of Vaccines. Dr. Salvatore is a Fellow of the Infectious Diseases Society of America (IDSA) and has been elected Vice President of the Infectious Disease Society of New York (IDSNY)